MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 6, 2007; DOI: 10.1124/mol.106.033407


0026-895X/07/7106-1582-1590$20.00
Mol Pharmacol 71:1582-1590, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.033407v1
71/6/1582    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, P.
Right arrow Articles by Akk, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, P.
Right arrow Articles by Akk, G.

Natural and Enantiomeric Etiocholanolone Interact with Distinct Sites on the Rat {alpha}1beta2{gamma}2L GABAA Receptor

Ping Li, John Bracamontes, Bryson W. Katona, Douglas F. Covey, Joe Henry Steinbach, and Gustav Akk

Departments of Anesthesiology (P.L., J.B., J.H.S., G.A.) and Molecular Biology and Pharmacology (B.W.K., D.F.C.), Washington University School of Medicine, St. Louis, Missouri

We have studied the ability of the androgen etiocholanolone and its enantiomer (ent-etiocholanolone) to modulate rat {alpha}1beta2{gamma}2L GABAA receptor function transiently expressed in human embryonic kidney cells. Studies on steroid enantiomer pairs can yield powerful new information on the pharmacology of steroid interactions with the GABAA receptor. Both steroids enhance currents elicited by GABA, but ent-etiocholanolone is much more powerful than etiocholanolone at producing potentiation. At a low GABA concentration (0.5 µM, <EC5), the presence of 10 µM ent-etiocholanolone potentiates whole-cell currents by almost 30-fold, whereas 10 µM etiocholanolone merely doubles the peak response. At higher GABA concentration (5 µM, ~EC25), the potentiation curve for ent-etiocholanolone is positioned at lower concentrations than that for etiocholanolone. Single-channel kinetic analysis shows that exposure to etiocholanolone has a single effect on currents: the relative frequency of long openings is increased in the presence of steroid. But exposure to ent-etiocholanolone produces two kinetic effects: an increase in the relative frequency of long openings and a decrease in the frequency of long closed times. The presence of etiocholanolone does not inhibit potentiation by ent-etiocholanolone, suggesting that etiocholanolone is unable to interact with the sites through which ent-etiocholanolone modifies receptor function. The double mutation {alpha}1(N407A/Y410F) prevents potentiation by etiocholanolone but not by ent-etiocholanolone, and the {alpha}1(Q241A) and {alpha}1(I238N) point mutations fully abolish potentiation by etiocholanolone but not by ent-etiocholanolone. We conclude that etiocholanolone and its enantiomer interact with distinct sites on the {alpha}1beta2{gamma}2L GABAA receptor.


Received for publication December 11, 2006.

Accepted for publication March 6, 2007.

Address correspondence to: Gustav Akk, Department of Anesthesiology, Washington University in St Louis, Campus Box 8054, 660 S. Euclid Ave, St Louis, MO 63110. E-mail: akk{at}morpheus.wustl.edu




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
G. Akk, P. Li, J. Bracamontes, and J. H. Steinbach
Activation and Modulation of Concatemeric GABA-A Receptors Expressed in Human Embryonic Kidney Cells
Mol. Pharmacol., June 1, 2009; 75(6): 1400 - 1411.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. R. Bracamontes and J. H. Steinbach
Steroid Interaction with a Single Potentiating Site Is Sufficient to Modulate GABA-A Receptor Function
Mol. Pharmacol., April 1, 2009; 75(4): 973 - 981.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Akk, P. Li, J. Bracamontes, D. E. Reichert, D. F. Covey, and J. H. Steinbach
Mutations of the GABA-A Receptor {alpha}1 Subunit M1 Domain Reveal Unexpected Complexity for Modulation by Neuroactive Steroids
Mol. Pharmacol., September 1, 2008; 74(3): 614 - 627.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. Li, H.-J. Shu, C. Wang, S. Mennerick, C. F. Zorumski, D. F. Covey, J. H. Steinbach, and G. Akk
Neurosteroid migration to intracellular compartments reduces steroid concentration in the membrane and diminishes GABA-A receptor potentiation
J. Physiol., November 1, 2007; 584(3): 789 - 800.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics